Author:
Autenshlyus A. I.,Davletova K. I.,Mikhaylova E. S.,Proskura A. V.,Varaksin N. A.,Bogachuk A. P.,Sidorov S. V.,Lyakhovich V. V.,Lipkin V. M.
Subject
General Chemistry,Biochemistry,General Medicine,Biophysics
Reference10 articles.
1. Salamat, F., Niakan, B., Keshtkar, A., et al., Subtypes of benign breast disease as a risk factor for breast cancer: a systematic review and meta-analysis, Iran. J. Med. Sci., 2018, vol. 43, no. 4, pp. 355–364.
2. Collins, D.P., Cytokine and cytokine receptor expression as a biological indicator of immune activation: important considerations in the development of in vitro model systems, J. Imm. Meth., 2000, vol. 243, nos. 1–2, pp. 125–145.
3. Kostanyan, I.A., Astapova, M.V., Navolotskaya, E.V., et al., A biologically active fragment of the differentiation factor of the HL-60 line cells: Identification and properties, Russ. J. Bioorg. Chem., 2000, vol. 26, no. 7, pp. 450–456.
4. Liu, C.C., Yang, H., Zhang, R., et al., Tumour-associated antigens and their anti-cancer applications, Eur. J. Cancer Care, 2017, vol. 26, no. 5, pp. 1–2.
5. Dyrstad, S.W., Yan, Y., Fowler, A.M., et al., Breast cancer risk associated with benign breast disease: systematic review and meta-analysis, Breast Cancer Res. Treat., 2015, vol. 149, no. 3, pp. 569–575.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献